SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma

Xiajing Qian; Ming Jin; Yanping Bei; Chongchang Zhou; Shuai Fang; Kaitai Liu

doi:doi:10.18632/aging.205597

← Back

Research Paper Volume 16, Issue 5 pp 4423—4444

SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma

Figure 5. A nomogram based on SLC20A1 expression and clinical features. (A) Nomogram to predict the overall survival (OS) of the 1^st, 3^rd, and 5^th years for HNSCC cases. (B) Calibration curve of the nomogram prognostic model. (C) ROC curve of the nomogram for predicting the overall survival (OS) of the 1^st, 3^rd, and 5^th years.